The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Last updated: June 27, 2011
Sponsor: AstraZeneca
Overall Status: Completed

Phase

N/A

Condition

Tourette's Syndrome

Bipolar Disorder

Depression

Treatment

N/A

Clinical Study ID

NCT01377896
NIS-NZA-XXX-2011/1
  • All Genders

Study Summary

'Real life' retrospective patient cases (10) to provide an objective and robust analytical report of patient management and prescriptions behaviours for Schizophrenia, Bipolar disorders and Major depressive disorders.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients diagnosed with one of the following conditions: Schizophrenia, Bipolardisorders and Major depressive disorders.

Exclusion

Exclusion Criteria:

  • Patients who have not been diagnosed with the conditions as outlined in the Inclusioncriteria.

Study Design

Total Participants: 221
Study Start date:
July 01, 2010
Estimated Completion Date:
October 31, 2010